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ABSTRACT
Among patients with chronic cardiopulmonary disease,
increasing healthy behaviors improves outcomes, but
such behavior changes are difﬁcult for patients to make
and sustain over time. This study aims to demonstrate
how positive affect and self-afﬁrmation improve health
behaviors compared with a patient education control
group. The patient education (PE control) patients
completed a behavioral contract, promising to increase
their physical activity or their medication adherence
and received an educational guide. In addition to the
contract and guide, the positive affect/self-afﬁrmation
intervention (PA intervention) patients also learned to
use positive affect and self-afﬁrmation to facilitate
behavior change. Follow-up was identical. In 756
patients, enrolled in three randomized trials, the PA
intervention resulted in increased positive affect and
more success in behavior change than the PE control
(p<.01). Behavior-speciﬁc self-efﬁcacy also predicted
success (p<.01). Induction of positive affect played a
critical role in buffering against the adverse behavioral
consequences of stress. Patients who experienced
either negative psychosocial changes (p<.05) or interval
negative life events (p<.05) fared better with the PA
intervention than without it. The PA intervention
increased self-efﬁcacy and promoted success in
behavior change by buffering stress.
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INTRODUCTION
Patients with coronary artery disease, hypertension,
and asthma frequently experience adverse events
that could be prevented by adopting new health
behaviors, such as increasing physical activity or
improving medication adherence. However,
engaging in such behavior change and sustaining it
over time are difﬁcult for most patients with
cardiopulmonary disease. For example, among
angioplasty patients, increasing physical activity
reduces all-cause mortality by 25 % over 1–2 years
[1, 2], but 60 % of patients fail to achieve
recommended physical activity levels [3]. Among
patients with mild-moderate asthma, increased
lifestyle physical activity can yield cardiovascular
and pulmonary beneﬁts [4, 5], but most asthmatics
avo id exe r c i s e becau s e i t may induce
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Implications
Practice: A brief script that instructs patients
about positive affect and self-afﬁrmation can
increase successful behavior change in patients
with chronic cardiopulmonary disease.
Policy: Resources should be devoted to the
dissemination of freely available, no cost
interventions, which are not marketed, precisely
because they are free.
Research: Research needs to be directed on how
to harness positive affect to address a broader
array of patient issues.
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bronchoconstriction [6]. Among African-American
hypertensives, lack ofmedication adherence is a major
contributor to uncontrolled blood pressure control [7]
that results in signiﬁcantly increased mortality [8].
Thus, these three groups of patients with chronic
cardiopulmonary disease often experience adverse
sequelae because they cannot make and sustain
behavior change. To address this dilemma and
develop innovative new approaches to behavior
change, the National Heart, Lung, and Blood Institute
designed an initiative to evaluate promising
approaches from basic behavioral research that had
potential to apply to clinical practice [9].
Drawing upon on a large body of basic behavioral
research about positive affect and self-afﬁrmation,
Cornell Translational Behavioral Science Research
Consortium evaluated an intervention that
combined positive affect and self-afﬁrmation to
motivate health behavior change in these patients
with chronic cardiopulmonary disease [10–12].
Three randomized trials were intentionally designed
to simultaneously test an identical positive affect/
self-afﬁrmation intervention in different populations
with the goal of behavior change, albeit with
different outcomes (i.e., physical activity and
medication adherence). This was the ﬁrst time ever
that the same behavioral intervention was evaluated
synchronously in parallel randomized trials using
the same methods, and common clinical and
psychosocial measures, including measures of affect,
stress, social support, and self-efﬁcacy. Thus, by
design, the three randomized trials had a common
theoretical perspective and substantial cross-linking
themes woven through their objectives and
methodology [13].
We previously reported the results of these
randomized trials in angioplasty patients, mild-
moderate asthma patients, and African-American
hypertensives that evaluated a positive affect/self-
afﬁrmation intervention [13–16]. In the angioplasty
and hypertension trials, the positive affect
intervention resulted in signiﬁcant improvement in
outcomes vs. the control [15, 16]; in the asthmatics,
there was no difference between treatment and
control [14]. The overall goal of this preplanned
cross-trial analysis is to elucidate the psychosocial
mediators and moderators of success in behavior
change, and speciﬁcally the impact of induced
positive affect, across multiple populations.
Positive affect has been shown to inﬂuence health
in multiple ways [17]. Positive affect interventions
have had marked effects on people’s cognitive
processes, social behavior, motivation, self-efﬁcacy,
and ability to cope with stressful life events. People
with positive affect have felt more intrinsically
motivated and were more able to try new things
[18–20]. Positive affect also increased an individual’s
perception of the value of the ultimate goal [21],
their belief that the immediate behavioral goal can
be achieved, and their expectation that reaching the
behavioral goal will lead to the better outcomes [22].
Self-afﬁrmation interventions have enhanced
people’s ability to overcome negative expectations
of their own ability to stay resolved to avoid
unhealthy behaviors and to practice positive ones
[10–12].
We hypothesized that the positive affect/self-
afﬁrmation intervention would increase self-efﬁcacy
for behavior change. We also hypothesized that
positive affect/self-afﬁrmation would also buffer
against an adverse behavioral impact of negative
psychosocial changes including increased perceived
stress and depressive symptoms. The objective of
this analysis of 756 patients enrolled in the three
trials is to elucidate the mechanism whereby the
positive affect and self-afﬁrmation intervention
resulted in signiﬁcant improvements in health
behaviors in comparison to the PE control group
and to explore the similarities and differences
between the trials.
METHODS
Population—The 242 coronary artery disease patients
had just undergone angioplasty and had been
cleared by their cardiologists to resume physical
activity [16]. The 252 asthma patients had mild-
moderate disease [14], and more than two thirds of
the 256 African-American hypertensives had
uncontrolled hypertension [15]. Patients with either
asthma or hypertension were recruited through an
academic primary care practice. The detailed
common methods of the three trials have been
published [13].
Measures—All three trials employed the Charlson
Comorbidity Index [23] , the Centers for
Epidemiologic Studies Depression Scale 10-item
version [24], the Perceived Stress Scale, [25], the
Positive and Negative Affect scale [26, 27], the MOS
social support scale (which measures positive social
support) [28], the Morisky adherence scale [29], and
the Paffenbarger Activity and Exercise Index [30, 31].
All patients completed contracts specifying the
behavior that they would adopt [13], what they
would do, when, how often, and how much they
would do [32, 33]. In order to evaluate their self-
efﬁcacy for the behavior, patients were asked to rate
how conﬁdent they were that they would be able to
fulﬁll the contract. Patients rated themselves on a
scale of 0–10, with 0 indicating no conﬁdence and
10 indicating complete conﬁdence. [32, 33]
All psychosocial measures were obtained at
baseline and at 12 months. For depressive symptoms,
the usual cutoff of 10 on the CES-D was used to deﬁne
patients who had increased depressive symptoms. To
deﬁne change in other psychosocial measures such as
perceived stress and social support, the 75th and 25th
percentiles for within-patient change were ﬁrst
deﬁned, with the cutoffs generated from the
distribution of the patients’ scores from all three trials.
Disease-speciﬁc severity measures included the Seattle
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angina questionnaire [34], stage of hypertension [35],
and the Severity of Asthma scale [36]. For the
angioplasty trial, patients with an anginal frequency
under 50 from the Seattle angina questionnaire were
classiﬁed as having severe disease, those rating 50–74
were classiﬁed as moderate, and those rating 75 or
higher were classiﬁed as mild [34]. For the
hypertension trial, patients with blood pressures
>160/100 were classiﬁed as severe, 140–159/90–99
asmoderate, and <140/90 asmild [35]. For the asthma
trial, patients with a Severity of Asthma [37] score >10
were classiﬁed as severe disease, those with 5–10 as
moderate, and those <5 as mild.
Patient education and positive affect/self-affirmation
intervention groups—The PE control group was not a
usual-care group. Patients in both the intervention
and control groups in all three trials received a
disease-speciﬁc workbook that explained the
importance of the behavior (e.g., increasing physical
activity or taking medications). The workbooks had
stories about patients who successfully overcame
obstacles to behavior change [38–40]. Patients were
asked to select a behavior for which they had a high
self-efﬁcacy (≥8); for the selected behavior, all
patients also completed a contract that stated exactly
what behavior they would do, when, how often, and
for how long they would do it. Patients were
required to select behaviors for which they had a
high self-efﬁcacy because to do otherwise would
increase the failure rate. All patients were also given
a pedometer in order to insure uniformity of the
intervention, although the outcome was physical
activity in two of the trials and medication
adherence in hypertensives. All patients in both
arms of the three trials received telephone follow-up
every 2 months for 1 year, and, at each follow-up,
patients were asked about their physical activity or
medication adherence behavior and their self-
efﬁcacy on a scale of 0–10 for continuing the
behavior. Thus, the PE control group received equal
attention including workbooks, behavioral contracts,
pedometers, and follow-up calls; the only difference
was they did not receive the positive affect/self-
afﬁrmation intervention.
Patients in the positive affect/self-afﬁrmation (PA
intervention) [41] group also received the workbook,
the contract, a pedometer, and telephone follow-ups at 2-
month intervals. In addition, the positive affect/self-
afﬁrmation group was taught how to use positive affect
and self-afﬁrmation [13]. At enrollment, patients in the
PA intervention groupwere asked to identify small things
that make them feel good and were told that, “Thinking
about these small things that make you feel good may
help you to overcome challenges and improve your
health” [13]. They were asked to think about these things
when they ﬁrst wake up in the morning and throughout
their day. For example, some patients induced their own
positive affect every day by taking a moment to enjoy
beautiful things, such as a sunrise or sunset. In addition,
the PA intervention group was sent a gift prior to each
follow-up call (i.e., an umbrella, desk clock, ﬂeece
blanket, stainless steel coffee mug, pen and key chain,
or duffel bag). For the self-afﬁrmation component of the
PA intervention, patients were also asked to think of
some proud moments in their lives or something they
had done that they were proud of and were told that
thinking about these things could help them overcome
challenges in carrying out their new health behavior.
For example, patients used self-afﬁrmation to
overcome obstacles by remembering how they had
reached their own goals in the past [13]. At each
follow-up, patients’ use of positive affect and self-
afﬁrmation interventionwere assessed and the positive
affect/self-afﬁrmation script interventionwas repeated.
Treatment fidelity—The research assistants involved in
the trials received the same training and used identical
scripts for the PA intervention and PE control groups,
respectively [13]. To ensure that the interventions were
applied equally in the different trials, we evaluated the
elements that were common to the PA intervention
and the PE control groups, as well as the elements of
the PA intervention. One difference was that only
asthma patients were instructed in the use of the
pedometer at the time of enrollment. Likely a result of
this difference, a greater percentage of patients in the
asthma trial [42] than in the angioplasty trial or
hypertension trial (52 vs. 25 %, P<.0001) thought the
pedometer was helpful.
Overall, with regard to the PA intervention check,
70 % of the patients in all trials reported that they were
completely or mostly able to think about things that
made them feel good at each interval of follow-up,
whereas 50–60 % of patients said that they were
completely or mostly able to use self-afﬁrmation at each
follow-up interval. At the end of the trial, 60–70 % of
patients said that they had employed positive thoughts
daily, whereas 84–88 % said they used positive thoughts
either daily or weekly. Overall, about 50 % of patients
used self-afﬁrmation daily, whereas 80–88 % used it
either daily or weekly. About half of the patients thought
that using positive thoughts had helped them change
their behavior and roughly half of the patients thought
that self-afﬁrmation had been helpful in overcoming
barriers to behavior change.
Outcomes for this cross-study analysis—The asthma and
angioplasty trials were designed to increase physical
activity, whereas the hypertension trial was designed
to increase medication adherence and blood
pressure control. To conduct a cross-study analysis
of patients in all three trials, we needed to create a
common outcome (i.e., “success”). In the
angioplasty and asthma trials, patients who
increased their physical activity by more than the
prespeciﬁed clinically important difference
(336 kcal/week) were classiﬁed as a success. For
the hypertension trial, the JNC VII criteria were
used; patients whose blood pressure was <140/90
(or <130/80 if they had diabetes or renal disease)
were classiﬁed as a success [13, 35].
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Statistical analysis—Endpoints were available in 95 %
of patients randomized. Statistical modeling of
associations among multiple continuous outcomes,
such as path and structural equation models has
become routine [43]. In contrast, trials such as these
whose mixed outcomes include both discrete and
continuous outcomes pose challenging issues in data
analysis. To address this, we used a general framework
to model directed association between variables
representing binary and continuous outcomes. We
treated discrete outcomes as observed hidden
continuous variables and used a latent path model to
structurally construct directed association between
continuous variables, using an extension of the class
of models developed by Amemiya [44] and
Gueorguieva and Agresti [45]. To ﬁt this mixed-data
structural equation model, we used the full-
information maximum likelihood Monte Carlo EM
estimation procedure developed by Zhang and Wells
[46]. The estimates are calculated using a generalized
EM algorithm constructed by maximizing the
expected complete-data log-likelihood function (M-
step) and using a Monte Carlo approach to evaluate
the conditional expectations (E-step). For the analysis,
the self-efﬁcacy variable was a discrete version of the
highly skewed continuous self-efﬁcacy scale. Self-
efﬁcacy was coded as 1 if it was above the median
(>8) and 0 if it was below the median self-efﬁcacy
score. Several other categorizations for self-efﬁcacy
were ﬁt, but the results did not substantively differ
from those obtained using the median split.
Mediated moderator analyses were performed to
assess the role of other mediating variables (i.e.,
stress and self-efﬁcacy) in the link between
psychosocial changes and the ultimate behavior
change. One common approach to combine
moderation and mediation involves analyzing
moderation and mediation in piecemeal fashion
and interpreting their results jointly. With this
approach, moderation is usually tested with classical
regression analysis, in which the dependent variable
is regressed on the independent variable, the
moderator variable, and their product [47].
Mediation is typically tested separately using the
causal steps procedure [48]; however, the sequential
Baron and Kenny methodo logy canno t
simultaneously assess mediation and moderation
[49, 50]. Structural equation models provide a more
coherent approach for addressing mediation and
moderation; this approach, as in testing mediation,
characterizes the impact of moderation on the direct
and indirect effects. Using bootstrapping resampling
techniques [51], we constructed critical values
needed for signiﬁcance tests of the product of
coefﬁcients to assess the direct and indirect effects,
as well as the moderation effects. The analysis
controlled for age, gender, race, disease severity
(measured as mild, moderate, or severe for each
disease), body mass index, and trial clustering.
Classical path coefﬁcients are the partial
regression coefﬁcients that measure the extent of
one variable’s effect on another in the path model,
controlling for other prior variables. In our analysis,
however, we have a mix of binary and continuous
outcomes with no easy interpretation because the
probit and traditional continuous path coefﬁcients
are on different scales. Consequently, to prevent
misinterpretation of our results, the mixed path
coefﬁcients are not shown.
RESULTS
All three randomized trials were designed to achieve
success in behavior change, although the behaviors
targeted differed by trials. In angioplasty patients
and in hypertensive patients, the positive affect [41]
intervention resulted in a signiﬁcant improvement in
outcomes vs. the PE [21] control. For asthmatic
patients, however, there was no difference in
outcomes between the randomization groups [14].
This analysis, by design, combines the patients from
the three trials in order to identify common
mediators and moderators of success in behavior
change.
Figure 1 shows the CONSORT diagram for the
three trials after enrollment; the CONSORT
diagram for each trial has been published [14–16].
Table 1 provides a context for the cross-study
analysis, showing that patients in the three trials
differed signiﬁcantly in their demographic and
clinical characteristics. Angioplasty patients were
predominantly male and often working. Patients in
the hypertension trial were predominantly older
African-American women, less than half of whom
were working. Patients in the asthma trial were
younger, working, single women. About 30 % of the
patients in the angioplasty and hypertension trials
had signiﬁcant comorbidity, whereas the majority of
asthma patients did not. Using disease-speciﬁc
measures of severity, more patients in the
angioplasty and hypertension study had severe
disease than those in the asthma trial (P<.05). All
analyses adjust for these demographic and clinical
differences, as well as the speciﬁc trial.
Patients in all three trials had very similar
psychosocial characteristics [42]. The patients scored
around 33–35 for positive affect, ranking at about
the 57th percentile for the general population. [26]
The negative affect score was higher than in the
general population, with patients scoring 19–23, at
around the 75th–85th percentile for the general
population [26]. About 40 % of patients in each trial
had important depressive symptoms (CESD-10
≥10), exhibiting a considerably higher rate than
the 12 % rate reported in well, older adults [52]. In
all three trials, the MOS social support was 78–80,
indicating signiﬁcant support [28]. In all three trials,
the perceived stress scale was 14–15, indicating
moderate stress [53]. At baseline, patients had a
high self-efﬁcacy for their selected behavior change
averaging between 8.6 and 9.5; 81 % had a self-
efﬁcacy of ≥8. Almost 98 % of patients in all trials
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had high expectations that engaging in the behavior
would be beneﬁcial.
PATH MODELS: MEDIATORS AND MODERATORS
OF SUCCESS ACROSS THE TRIALS
Induction of positive affect had a signiﬁcant beneﬁt
on behavior change; overall, 53 % of those in the PA
intervention, but only 41 % of those in the PE
control had behavioral success (P<.001) [54]. A
PATH model of the success across the trials was
developed to evaluate mediators and moderators of
successful behavior change. As shown in Fig. 2, the
primary dependent variables are change in
perceived stress, self-efﬁcacy for behavior change,
and success in behavior change. The continuous
variables in the path models are baseline to closeout
changes in perceived stress, positive affect),
depression [52], and social support. The model
controls for age, body mass index (BMI), disease
severity, gender, race, and a trial level random
effect.
Figure 2 shows that PA intervention enabled
patients to maintain success in behavior change in
the face of increased perceived stress, new
depressive symptoms, or decreased social support.
Increases in positive affect were associated with
decreased stress and increased success in behavior
change (P<.01). The signs of the partial associations
computed from our path analysis are reported in
Fig. 2. With an increase in positive affect of 4 or
more, perceived stress decreased by 4.2 points, and,
with an increase in positive affect of 2–4, perceived
stress dropped by 3.0 points. As the level of positive
affect increased, perceived stress decreased to a
greater degree.
Larger increases in Positive and Negative Affect
Schedule (PANAS) positive affect in the PA
intervention group were associated with greater
reductions in perceived stress (P<.01). Increases in
PANAS positive affect (P<.01), decreases in
depressive symptoms (P<.01), and increases in
social support (P<.05) are associated with reduction
in stress, as expected. Conversely, decreased
PANAS positive affect (P<.01), new depressive
symptoms (P<.01), and decreased support (P<.01)
were associated with increased stress.
Although the demographic characteristics did not
identify patients with more or less success in
behavior change, one clinical characteristic—disease
severity—did. Patients with severe disease had less
success overall, than those with mild-moderate
disease but beneﬁtted more from the PA intervention.
For example, among patients with severe disease,
49 % of patients who received the PA intervention
had success vs. 27 % of the PE control (P<.05).
Among those with mild-moderate disease, only 53 %
in the PA intervention vs. 43 % in the PE control
achieved success (P<.01). Independently, none of the
baseline psychosocial characteristics were predictors
of success.
CLINICAL CONTEXT FOR THE PATH MODEL
To put the PATH model in context, Table 2 shows
success in healthy behavior change according to the
Enrolled (n=845)
Not Randomized (n=89)
Lost to Follow-up (n=23)
Asthma (n=1)
Angioplasty (n=10)
Hypertension (n=12)
Lost to Follow-up (n=31)
Asthma (n=5)
Angioplasty (n=6)
Hypertension (n=16)
Included in Primary Analysis
Asthma (n=128)
Angioplasty (n=115)
Hypertension (n=125)
Included in Primary Analysis
Asthma (n=130)
Angioplasty (n=122)
Hypertension (n= 131)
Allocated to Control (n=371)
Asthma (n=128) 
Angioplasty (n=118)
Hypertension (n=125)
Allocated to Treatment (n=386)
Asthma (n=130) 
Angioplasty (n =124) 
Hypertension (n=131)
Randomized (n=756)
Fig 1 | CONSORT Consolidated Standards of Reporting Trials diagram. Flow of participants from enrollment to completion of
the ﬁnal follow-up assessment
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threshold deﬁnitions for psychosocial change cited in
the table. These data are presented to help clinicians
evaluate the potential treatment beneﬁt for patients.
Mediators of success—In general, changes in perceived
stress mediated success, regardless of intervention
group. Successful behavior change was observed (P
<.05) in 56 % of patients whose perceived stress
decreased over follow-up, but only in 43 % of those
whose perceived stress increased. Patients who had
increased perceived stress were more likely to have
success; however, if they received the positive affect/
self-afﬁrmation intervention (54 % vs. 32 %, P<.01).
Behavior-speciﬁc self-efﬁcacy over time was also a
mediator of success (P<.01). Among those with high
self-efﬁcacy (i.e., ≥8), 44 % of those in the PE control
and 55 % of those in the PA intervention group had
success (P<.01), whereas among those with low self-
efﬁcacy (<8), 32 % of those in the PE control and 43 %
of those in the PA intervention had success (P>.1).
Negative psychosocial changes—Patients whose
perceived stress increased were more likely to
succeed with behavior change if they received the
PA intervention vs. PE control (54 vs. 32 %, P<.01).
Similarly, patients who became newly depressed
were much more likely to maintain behavior change
if they received the PA intervention vs. the PE
control (56 vs. 25 %, P<.01). Those who had
decreased social support were more likely to maintain
behavior change if they received the PA intervention
vs. PE control (54 vs. 37 %, P<.05). With one or more
of these negative psychosocial challenges, patients in
the PA intervention were much more successful in
maintaining healthy behavior change than the PE
control (53 vs. 34 %, P<.05). Thus, induction of
positive affect buffered against the potential adverse
behavioral impact of increased stress, new depressive
symptoms, or decreased social support.
Positive psychosocial changes—Positive psychosocial
events occurred signiﬁcantly more frequently in
the PA intervention group than in the PE control
group (40 vs. 48 %, p<.05). Speciﬁcally, more
patients in the PA intervention than in the PE
control had decreased stress, decreased depressive
symptoms, and increased social support (P<.05).
Patients whose stress decreased were more likely to
maintain healthy behavior change if they received
the PA intervention vs. PE control (63 vs. 47 %, P<
0.05). Moreover, patients whose depressive
symptoms abated or those whose support increased
were more likely to maintain healthy behavior change
if they received the PA intervention vs. PE control
(P<.05 for both). Among patients who had positive
psychosocial changes, Table 2), those in the PA
Table 1 | Demographic, clinical, and psychosocial characteristics at baseline in the three trial populations
Angioplasty Hypertension Asthma P value
Demographic
Age 63±11 58±12 42±12 <.0001
Women 30 % 80 % 75 % <.0001
African American 11 % 100 % 22 %
Caucasian 81 % 0 % 54 %
Latino 13 % 3 % 31 % <.0001
Married 69 % 25 % 32 % <.0001
Never married 11 % 28 % 42 % <.0001
Completed college 55 % 26 % 61 % <.0001
Working 56 % 40 % 73 % <.0001
Retired 31 % 27 % 1 % <.0001
Clinical
Comorbidity <.0001
1-2 46 % 41 % 95 %
> 3 29 % 35 % 5 %
Diabetes 25 % 36 % 7 % <.0001
Myocardial infarction 28 % 5 % 0 % <.0001
Stroke 7 % 11 % 0 % <.0001
Disease severity <.05
Mild 47 % 41 % 45 %
Moderate 40 % 46 % 48 %
Severe 14 % 13 % 7 %
Psychosocial
PANAS positive 33 35 35 <.001
PANAS negative 23 19 20 <.0001
CES-D 10 9.2 8.5 8.7 n.s.
Social support 80 76 78 n.s.
Perceived stress 14 14 15 n.s.
Self-efﬁcacy for behavior change 8.8 9.5 8.6 <.05
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intervention group weremore likely to have success in
behavior change than in the PE control group [54].
INTERVAL LIFE EVENTS OR INTERVAL MEDICAL EVENTS
During follow-up in all three trials, patients who
experienced interval negative life events, such as deaths
of relatives or friends, job loss, or ﬁnancial or family crises,
had 24 %more success with the PA intervention than did
the PE control (55 vs. 31 %, P<.02). Patients who did not
experience negative events had only about 10 % more
success with the PA intervention than the PE control.
Overall, 16 % of patients experienced adverse
clinical events during follow-up. Among patients who
did not report adverse clinical events, those in the PA
intervention fared better than those in the PE control
in successful behavior change (55 vs. 43 %), (P<.01).
Among those who did report interval medical events,
those in the PA intervention fared better in successful
behavior change than those in the PE control [55], but
the difference was not signiﬁcant.
Differences between the trials—Table 3 shows the
similarities and differences in the success of
behavior change in the three populations. The PA
intervention helped patients in the angioplasty and
hypertension trials, but did not help those in the
asthma trial succeed with behavior change, despite
increased stress [42]. Of note, angioplasty patients
who received the PA intervention had about twice
the increase in PANAS positive scores compared
with asthma patients (5.1 vs. 2.9, P<.01) and a
ﬁvefold higher increase in PANAS scores compared
with hypertension patients (5.1 vs. 0.9, P<.01). In all
trials, the PA intervention helped patients who
became depressed or who had decreased social
support to maintain the behavior in comparison to
the PE control group.
In each trial, when positive psychosocial events
occurred, the PA intervention group demonstrated
higher rates of success vs. the PE control (angioplasty,
53 vs. 42 %; hypertension, 41 vs. 37 %; asthma, 51 vs.
42 %). With decreased stress, angioplasty and
hypertension patients in the PA intervention
group had greater success than the PE control,
whereas there was no difference between groups
for asthma patients. In all three trials, the PA
intervention group did better than the PE control
if depressive symptoms abated.
Overall, 19 % of angioplasty, 9 % of hypertension,
and 20 % of asthma patients experienced an interval
medical event. The impact of interval medical
events differed among the trials. In the hypertension
and asthma trials, those with interval events fared
better with the PA intervention; however, in the
angioplasty, those with interval events fared worse
with the PA intervention than PE controls. In
angioplasty, patients with interval events exhibited
a decrease in self-efﬁcacy and positive affect. In
asthma and hypertension patients, interval events
did not decrease self-efﬁcacy and positive affect
patients did better, displaying the inverse of the
Fig 2 | A PATH model: simultaneous mediation and moderation of the positive affect–self-afﬁrmation intervention. Controls
for age, BMI, disease severity, gender, race, and trial clustering. Asterisks indicate strength of association: *P<.01, **P<.05.
Plus signs indicate direct relationship: + Increased depression leads to increased stress; decreased depression leads to
decreased stress. + Increased positive affect leads to increased self-efﬁcacy; decreased positive affect leads to decreased
self-efﬁcacy. + Increased self-efﬁcacy leads to increased behavior change; decreased self-efﬁcacy leads to decreased
behavior change. Minus signs indicate inverse relationship: − Increased social support leads to decreased stress; decreased
social support leads to increased stress. − Increased positive affect leads to decreased stress; decreased positive affect
leads to increased stress. − Increased stress leads to decreased self-efﬁcacy; decreased stress leads to increased self-
efﬁcacy. Numbers indicate the following: 1 Increased interval medical events leads to decreased self-efﬁcacy. 2 Increased
positive affect intervention leads to increased behavior change. 2 Increased positive affect intervention leads to increased
self-efﬁcacy. 3 Increased positive affect intervention leads to decreased stress
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trend observed in angioplasty patients. It should be
noted that the medical events reported by
angioplasty patients were often more serious than
those reported by asthma and hypertensions
patients.
Specificity of the intervention—It is important to note
that the intervention impact was speciﬁc to the
behavior cited in the behavioral contract, regardless of
randomization group. For the angioplasty and asthma
trials, the contract was based on physical activity; over
the 12 months, 47 % of patients in the angioplasty trial
and 46 % of those in the asthma trial increased their
physical activity by more than 336 kcal, whereas only
23 % of those in the hypertension trial did so. The
mean within-patient change in physical activity was
470 kcal in angioplasty, 405 kcal in asthma, but only
20 kcal in hypertension (P<.01). In hypertension, the
contract was based on medication adherence. Using
the Morisky measure for adherence, 38 % of
hypertension patients were completely adherent at
baseline, a rate that rose to 53 % by the end of
12 months. In contrast, 51 % of the angioplasty
population reported adherence, both at baseline and
at 12 months. Likewise, the asthma population
reported nearly identical adherence at baseline and
12months (i.e., 24% at baseline and 29% at 12months
(P<.01).
DISCUSSION
Although positive affect and self-afﬁrmation have shown
promise in small studies [10, 11, 56–62], the three
recently published studies are the ﬁrst randomized trials
in patients with chronic disease that have assessed the
efﬁcacy of intervention based on positive affect and self-
afﬁrmation to motivate behavior change. The positive
affect/self-afﬁrmation intervention was identical in all
three trials. In all trials, the two randomization groups
received identical patient education, individually tailored
behavioral contracts, and equal attention through follow-
ups every 2 months. The only differences were that the
PA group was taught a script about how to induce
positive affect and how to use self-afﬁrmation to
overcome barriers to behavior change and they received
small, unexpected gifts prior to their follow-ups. Across
all three trials, patients reported using the positive affect/
self-afﬁrmation strategy to fulﬁll their behavioral
contract, and their behavior changes were speciﬁc to
the contract that theymade. The ﬁnal positive affect/self-
afﬁrmation intervention was adapted and tailored
through the ﬁndings of parallel qualitative studies in the
three different patient populations [38, 39, 63] and was
pilot-tested and reﬁned in parallel pilot studies.
These concurrent trials with parallel methods afford
an unprecedented opportunity to elucidate the
psychosocial mediators and moderators of success in
behavior change and, speciﬁcally, the impact of
induced positive affect. As hypothesized, self-efﬁcacy
Table 2 | Success in behavior change according to randomization group combining the three trials according to changes in
status between baseline and 12 months
Patient education
control (n=354)
Positive affect/
self-afﬁrmation (n=362)
Negative psychosocial changes
Increased perceived stress 32 % (75) 54 % (84) <.001
Newly depressed 22 % (24) 55 % (29) <.01
Decreased social support 37 % (76) 54 % (85) <.05
Total negative changes
0 45 % (222) 52 % (214) n.s.
≥1 36 % (133) 63 % (14*) <.05
Positive psychosocial changes
Decreased stress 48 % (79) 63 % (89) <.05
Decreased depressive symptoms 39 % (53) 57 % (70) <.05
Increased social support 47 % (85) 65 % (90) <.05
Total positive changes
0 38 % (211) 45 % (187) n.s.
≥1 45 % (144) 61 % (175) <.001
Life events
None 44 % (227) 53 % (234) <.05
Negative life events 31 % (51) 55 % (55) <.05
Positive life events 38 % (77) 51 % (73) n.s.
Interval medical events
No 43 % (299) 55 % (302) <.01
Yes 30 % (56) 40 % (60) n.s.
For MOS social support, an increase in support was deﬁned as an increase >7.8 (the 75th percentile for within-patient change); a decrease in support was
deﬁned as a fall of −6.5 (the 25th percentile for within-patient change). Using these cutoffs, patients with increased social support demonstrated a mean
increase of 20 points and those with decreased support demonstrated a mean decrease of 20 points. For perceived stress, an increase in stress was
deﬁned as an increase greater than +2 (the 75th percentile for within-patient change), while a decrease in stress was deﬁned as a fall of −7. Patients with
decreased stress showed an average decrease of 12 points and those with increased stress showed an increase of 7 points. At 12 months, patients were
also asked whether they had experienced any major negative or positive life events over the last year, and if so, what events occurred.
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over time predicted sustained success in behavior
change [22, 64]. Self-efﬁcacy, a key concept in Social
Cognitive Theory, inﬂuences the direction, intensity,
and persistence of behavior change [64].
A structural equation model (see Fig. 2) was used
to assess the mechanism through which the positive
affect/self-afﬁrmation intervention worked to
increase the success in behavior change. The PATH
analysis shows that positive affect has mediation
effects for behavior change for both self-efﬁcacy and
perceived stress. With regard to stress buffering, PA
intervention patients were able to sustain behavior
change when their perceived stress was increased,
but the PE control patients were not. Thus, our
ﬁndings support the hypothesis advanced by
Pressman and Cohen that positive affect inﬂuences
health, at least in part, through its ability to buffer
the adverse consequences of increased perceived
stress [65, 66]. The stress buffering was greater in
angioplasty and hypertension patients, who were
older and sicker, than in asthma patients, who were
younger and less sick. The PA intervention was also
effective in buffering against a potential adverse
behavioral impact of depressive symptoms. Our
ﬁndings also support the hypothesis [65, 66] that,
despite increased depressive symptoms, the PA
intervention patients were able to sustain their
behaviors, but the PE control patients were not able
to do so. Positive affect also appears to protect
against the adverse behavioral impact of decreased
social support. Thus, patients who received the PA
intervention and who experienced a negative
psychosocial change, whether the change involved
increased perceived stress, new depressive
symptoms, or decreased social support, did
signiﬁcantly better than patients who received only
the PE controls in sustaining behavior change. In
addition, patients who experienced negative life
events during follow-up did signiﬁcantly better with
the PA intervention. Thus, positive affect provided a
protection against the adverse behavioral inﬂuence
of negative psychosocial stressors [67].
In addition, more of the patients in the PA
intervention group experienced positive psychosocial
changes. Success was higher in the PA intervention
patients who had decreased perceived stress or whose
depressive symptoms lessened when compared to the
PE control patients. As hypothesized by Isen and
Reeve, positive affect may foster more ﬂexible
thinking and increase problem solving abilities,
including the ability to boost self-control [68, 69].
Positive affect leads to improved self-control by
increasing the ability to consider future and present
costs and beneﬁts and to see the connection between
their own efforts and their outcomes [70]. Cohen and
colleagues have hypothesized that positive affect might
increase social interactions, and have health beneﬁts,
by increasing social support and reducing the
consequences of social isolation [67, 71]. However, in
our data, similar proportions of patients in the two
randomization groups had increased social support.
The behavioral success rate of those with increased
social support in the PA intervention group was higher
than in the PE control. Thus, although the hypothesis
of Cohen and colleagues may be true in some
contexts, our data suggest that positive affect does not
increase social interaction and support; instead, it
enables patients to make the most of the beneﬁts
derived from increased social support and
protects against the adverse behavioral impact of
decreased support.
Table 3 | Similarities and differences in success in behavior change in the three populations according to negative and
positive changes in psychosocial status
Changes in psychosocial status Angioplasty Hypertension Asthma
Negative changes
Increased stress
PE control 18 % (28) 30 % (27) 55 % (20)
PA intervention 40 % (20) 59 % (29) 57 % (35)
Newly depressed
PE control 13 % (8) 22 % (9) 43 % (7)
PA intervention 57 % (7) 45 % (11) 67 % (9)
Decreased support
PE control 34 % (29) 36 % (22) 38 % (24)
PA intervention 59 % (32) 52 % (29) 50 % (24)
Positive changes
Decreased stress
PE control 38 % (24) 44 % (18) 56 % (36)
PA intervention 74 % (34) 63 % (24) 52 % (31)
Decreased depressive symptoms
PE control 19 % (16) 38 % (8) 50 % (26)
PA intervention 50 % (32) 75 % (12) 60 % (25)
Increased support
PE control 41 % (27) 48 % (31) 52 % (27)
PA intervention 67 % (24) 69 % (29) 62 % (37)
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The difference between the results of the angioplasty
and hypertension trials vs. the asthma trial still requires
explanation. One answer may lie in the efﬁcacy of the
PA intervention for sicker patients, as more of the
hypertension and angioplasty patients had severe
disease. The impact of the PA intervention was greatest
in angioplasty patients who had just faced a potentially
life threatening event [39], in contrast to hypertension
and asthma patients, who were enrolled from a practice
where they received their ongoing care [38, 63]. Thus,
the positive affect intervention may have had a greater
impact in the patients who hadmore severe conditions.
In particular, although there were no differences found
in outcome expectations, angioplasty patients may
have had a greater sense of urgency [39].
It is important to note that the dropout rate was
extremely low in all of the trials; overall, the
behavioral outcome was assessed in 95 % of patients.
This is unusual for physical activity interventions, as
previous studies have shown that 50 % will dropout
within 3–6 months [72]. Factors that likely minimized
dropout include patient-friendly educational
workbooks, an individualized behavioral contract,
follow-ups at reasonable intervals, and follow-up data
collection that was concise and focused on providing
support (rather than collecting data).
One limitation of the trials is that the different
outcome measures—physical activity for angioplasty
and asthma vs. medication adherence and blood
pressure control—necessitated the creation of a common
dichotomous measure of behavioral success for the
cross-study analysis. Another possible limitation is that
the PANAS measure of positive affect focuses on
activated affect, such as feelings of alertness,
determination, and enthusiasm, rather than on
nonactivated positive affect, including feelings of calm,
peacefulness, and contentment. Given this emphasis on
activated affect, we may have missed opportunities to
measure non-activated effects of the PA intervention.
We also acknowledge the practical consideration that
the small gifts, which have been found in many
experiments to effectively induce positive affect, can
raise the potential cost of the intervention. The small
gifts were part of the positive affect intervention [13].
There is an enormous literature about the impact of
self-efﬁcacy on success in behavior change. Patients
have the best chance of success if they have conﬁdence
that they can succeed; however, that conﬁdence or self-
efﬁcacy is prerequisite but not a guarantee. These trials
were speciﬁcally designed to evaluate the impact of
positive affect intervention on behavioral changes that
the patient selected because they had high self-efﬁcacy
for the speciﬁc contracted behaviors. Since behavior
change is difﬁcult formost patients, assessing the impact
of any intervention for which patients had a low self-
efﬁcacy would be an exercise in futility. The study
evaluated the impact of psychosocial, life and health
stressors on the ability of patients to sustain behavior
changes for which they had a high self-efﬁcacy or
conﬁdence; it did not evaluate environmental, genetic,
physiological, or neurological factors. Finally, research
assistants who collected the outcome data were not
universally blinded to the patients’ intervention status.
Many thoughtful analyses have evaluated the
potential impact of positive affect on health outcomes
and success [17, 69, 70, 73]. This is a unique NHLBI
supported and partnered effort to build new
interventions by translating ﬁndings in basic
behavioral science to address the needs of patients
with chronic illness. This study allowed us to create
and rigorously evaluate the efﬁcacy of an intervention
designed to increase positive affect among patients
with chronic cardiopulmonary disease.
The intervention created by this joint effort is
published and has freely available and easy-to-use
instructions for inducing everyday positive affect, as
well as instructions for self-afﬁrmation, when barriers
to sustaining changes in behavior are encountered [13].
The positive affect- self-afﬁrmation intervention builds
on the knowledge from a workbook, a straightforward
contract and regular follow-up, and can be employed to
assist patients in changing their behavior.
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